Pacira BioSciences, Inc.PCRXNASDAQ
Loading
Year-over-year book value per share growth
Percentile
P13
Within normal range
vs 5Y Ago
-0.3x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -1.22% |
| Q3 2025 | -0.94% |
| Q2 2025 | -3.40% |
| Q1 2025 | 2.36% |
| Q4 2024 | 3.75% |
| Q3 2024 | -14.68% |
| Q2 2024 | -0.75% |
| Q1 2024 | 2.40% |
| Q4 2023 | 4.59% |
| Q3 2023 | 2.19% |
| Q2 2023 | 4.88% |
| Q1 2023 | -1.04% |
| Q4 2022 | 0.52% |
| Q3 2022 | 1.05% |
| Q2 2022 | 5.15% |
| Q1 2022 | -3.45% |
| Q4 2021 | 1.37% |
| Q3 2021 | 3.80% |
| Q2 2021 | 4.84% |
| Q1 2021 | 4.23% |
| Q4 2020 | 4.58% |
| Q3 2020 | 48.15% |
| Q2 2020 | 3.31% |
| Q1 2020 | 4.76% |
| Q4 2019 | -0.42% |
| Q3 2019 | 3.33% |
| Q2 2019 | -0.22% |
| Q1 2019 | 5.98% |
| Q4 2018 | 6.23% |
| Q3 2018 | 3.20% |
| Q2 2018 | 4.08% |
| Q1 2018 | -0.60% |
| Q4 2017 | 5.18% |
| Q3 2017 | 0.68% |
| Q2 2017 | -8.73% |
| Q1 2017 | 20.78% |
| Q4 2016 | 2.74% |
| Q3 2016 | -6.55% |
| Q2 2016 | 0.53% |
| Q1 2016 | 2.90% |